260 related articles for article (PubMed ID: 37369808)
21. Prognostic Value and the Immune Microenvironment-associated Role of
Song Y; Wang Y; Yu T; He Y; Wang C; Wang F; Zhou Y
Anticancer Res; 2023 Dec; 43(12):5393-5408. PubMed ID: 38030175
[TBL] [Abstract][Full Text] [Related]
22. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma.
Xu F; Zhang Z; Zhao Y; Zhou Y; Pei H; Bai L
Gene; 2021 Aug; 795():145804. PubMed ID: 34175402
[TBL] [Abstract][Full Text] [Related]
23. Identify potential prognostic indicators and tumor-infiltrating immune cells in pancreatic adenocarcinoma.
Shi T; Gao G
Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35083488
[TBL] [Abstract][Full Text] [Related]
24. Mitophagy-mediated molecular subtypes depict the hallmarks of the tumour metabolism and guide precision chemotherapy in pancreatic adenocarcinoma.
Chen H; Zhang J; Sun X; Wang Y; Qian Y
Front Cell Dev Biol; 2022; 10():901207. PubMed ID: 35938160
[No Abstract] [Full Text] [Related]
25. Molecular subtyping based on TRP family and prognostic assessment for TRP-associated lncRNAs in pancreatic adenocarcinoma.
Li L; Xiao Z; He P; Zou W; Deng Z; Zhang G; Liu R
BMC Gastroenterol; 2022 Nov; 22(1):454. PubMed ID: 36371178
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive analyses and experimental verification of NETs and an EMT gene signature for prognostic prediction, immunotherapy, and chemotherapy in pancreatic adenocarcinoma.
Zhang J; Wang C; Yu Y
Environ Toxicol; 2024 Apr; 39(4):2006-2023. PubMed ID: 38088494
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive Analysis of 5-Methylcytosine (m
Wang R; Guo Y; Ma P; Song Y; Min J; Zhao T; Hua L; Zhang C; Yang C; Shi J; Zhu L; Gan D; Li S; Li J; Su H
Front Oncol; 2022; 12():851766. PubMed ID: 35433474
[TBL] [Abstract][Full Text] [Related]
28. High WFDC3 gene expression is associated with poor prognosis and reduced immune cells infiltration in pancreatic adenocarcinoma: A study using the TCGA database and bioinformatics analysis.
Wu W; Wang J; Hu Z; Zhao Y; Wang X; Bai N; Chen L; Gao P
Medicine (Baltimore); 2023 Oct; 102(42):e35595. PubMed ID: 37861515
[TBL] [Abstract][Full Text] [Related]
29. Identification of a Four Cancer Stem Cell-Related Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Adenocarcinoma.
Li S; Chen R; Luo W; Lin J; Chen Y; Wang Z; Lin W; Li B; Wang J; Yang J
Comb Chem High Throughput Screen; 2022; 25(12):2070-2081. PubMed ID: 35048799
[TBL] [Abstract][Full Text] [Related]
30. Cancer-associated fibroblast-related prognostic signature predicts prognosis and immunotherapy response in pancreatic adenocarcinoma based on single-cell and bulk RNA-sequencing.
Chen Y; Deng Q; Chen H; Yang J; Chen Z; Li J; Fu Z
Sci Rep; 2023 Sep; 13(1):16408. PubMed ID: 37775715
[TBL] [Abstract][Full Text] [Related]
31. Construction of an efferocytosis-related long non-coding ribonucleic acid scoring system to predict clinical outcome and immunotherapy response in pancreatic adenocarcinoma.
Zhou C; Gan X; Sun S; Wang L; Zhang Y; Zhang J
Biochem Biophys Rep; 2023 Sep; 35():101540. PubMed ID: 37692763
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Wang S; Chen S; Ying Y; Ma X; Shen H; Li J; Wang X; Lin Y; Liu B; Zheng X; Xie L
Front Cell Dev Biol; 2021; 9():676142. PubMed ID: 34291048
[TBL] [Abstract][Full Text] [Related]
33. Construction and evaluation of an aging-associated genes-based model for pancreatic adenocarcinoma prognosis and therapies.
Zhao J; Guan K; Xing J
Int J Immunopathol Pharmacol; 2023; 37():3946320231172072. PubMed ID: 37072128
[No Abstract] [Full Text] [Related]
34. Development and validation of a novel 3-gene prognostic model for pancreatic adenocarcinoma based on ferroptosis-related genes.
Yang J; Wei X; Hu F; Dong W; Sun L
Cancer Cell Int; 2022 Jan; 22(1):21. PubMed ID: 35033072
[TBL] [Abstract][Full Text] [Related]
35. Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases.
Mao M; Ling H; Lin Y; Chen Y; Xu B; Zheng R
Front Genet; 2021; 12():702102. PubMed ID: 34335699
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive characterization of extracellular matrix-related genes in PAAD identified a novel prognostic panel related to clinical outcomes and immune microenvironment: A silico analysis with
Chen X; Yuan Q; Liu J; Xia S; Shi X; Su Y; Wang Z; Li S; Shang D
Front Immunol; 2022; 13():985911. PubMed ID: 36311789
[TBL] [Abstract][Full Text] [Related]
37. Identification and validation of a novel anoikis-related long non-coding RNA signature for pancreatic adenocarcinoma to predict the prognosis and immune response.
Jiang Y; Ye Y; Huang Y; Wu Y; Wang G; Gui Z; Zhang M; Zhang M
J Cancer Res Clin Oncol; 2023 Nov; 149(16):15069-15083. PubMed ID: 37620430
[TBL] [Abstract][Full Text] [Related]
38. Relationship between a 7-mRNA signature of the pancreatic adenocarcinoma microenvironment and patient prognosis (a STROBE-compliant article).
He QL; Jiang HX; Zhang XL; Qin SY
Medicine (Baltimore); 2020 Jul; 99(29):e21287. PubMed ID: 32702921
[TBL] [Abstract][Full Text] [Related]
39. M2-phenotype tumour-associated macrophages upregulate the expression of prognostic predictors MMP14 and INHBA in pancreatic cancer.
Liang ZW; Yu J; Gu DM; Liu XM; Liu J; Wu MY; Xu MD; Shen M; Duan W; Li W
J Cell Mol Med; 2022 Mar; 26(5):1540-1555. PubMed ID: 35150061
[TBL] [Abstract][Full Text] [Related]
40. A prospective prognostic signature for pancreatic adenocarcinoma based on ubiquitination-related mRNA-lncRNA with experimental validation in vitro and vivo.
Wang Z; Yuan Q; Chen X; Luo F; Shi X; Guo F; Ren J; Li S; Shang D
Funct Integr Genomics; 2023 Aug; 23(3):263. PubMed ID: 37540295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]